Use of recombinant tissue plasminogen activator (alteplase) for treatment of acute ischemic stroke outside the criteria of guidelines and licenses is not uncommon. Most important situations of off ...

Also, the limit for mild strokes or rapidly resolving strokes will have to be reconsidered and modified for inclusion in future guidelines. Further evidence is expected from meta-analysis of all ...